Toxicity risk of non-target organs at risk receiving low-dose radiation: Case report

Radiation Oncology

Volumn 4, Issue 1, 2009, Pages

  Shueng, Pei Wei ^a,f,g   Lin, Shih Chiang ^a   Chang, Hou Tai ^a   Chong, Ngot Swan ^a   Chen, Yu Jen ^b,c   Wang, Li Ying ^d   Hsieh, Yen Ping ^e   Hsieh, Chen Hsi ^a,b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

^f NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^g ORIENTAL INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; LEVOFLOXACIN; METHYLPREDNISOLONE; PISUTAM; SEVATRIM; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CORTICOSTEROID;

ACUTE DISEASE; ADULT; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; BRONCHIECTASIS; CASE REPORT; COMPRESSION FRACTURE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DYSPNEA; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LOW ENERGY RADIATION; MALE; NONTARGET ORGAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION PNEUMONIA; TOMOTHERAPY; VERTEBRAL CANAL STENOSIS; BILE DUCT TUMOR; CERVICAL SPINE; INJURY; INTENSITY MODULATED RADIATION THERAPY; INTRAHEPATIC BILE DUCT; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SPINAL CORD TUMOR; SPINE; SPINE FRACTURE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADRENAL CORTEX HORMONES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CERVICAL VERTEBRAE; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; HUMANS; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOTHERAPY, INTENSITY-MODULATED; SPINAL FRACTURES; SPINAL NEOPLASMS; SPINE; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 76549135670     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-4-71     Document Type: Article

References (23)

1. Kataria T, Rawat S, Sinha SN, Garg C, Bhalla NK, Negi PS. Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies. Radiat Oncol 2006, 1:31. 10.1186/1748-717X-1-31, 1574325, 16939650.
2. Gong Y, Wang J, Bai S, Jiang X, Xu F. Conventionally-fractionated image-guided intensity modulated radiotherapy (IG-IMRT): a safe and effective treatment for cancer spinal metastasis. Radiat Oncol 2008, 3:11. 10.1186/1748-717X-3-11, 2373792, 18426607.
3. Shueng PW, Lin SC, Chong NS, Lee HY, Tien HJ, Wu LJ, Chen CA, Lee JJ, Hsieh CH. Total marrow irradiation with helical tomotherapy for bone marrow transplantation of multiple myeloma: first experience in Asia. Technol Cancer Res Treat 2009, 8:29-38.
4. Lee IJ, Seong J, Lee CG, Kim YB, Keum KC, Suh CO, Kim GE, Cho J. Early clinical experience and outcome of helical tomotherapy for multiple metastatic lesions. Int J Radiat Oncol Biol Phys 2009, 73:1517-24.
5. Schwarte S, Wagner K, Karstens JH, Bremer M. Radiation recall pneumonitis induced by gemcitabine. Strahlenther Onkol 2007, 183:215-7. 10.1007/s00066-007-1688-z, 17406804.
6. Kaminski JM, Shinohara E, Summers JB, Niermann KJ, Morimoto A, Brousal J. The controversial abscopal effect. Cancer Treat Rev 2005, 31:159-72. 10.1016/j.ctrv.2005.03.004, 15923088.
7. Alberts SR, Al-Khatib H, Mahoney MR, Burgart L, Cera PJ, Flynn PJ, Finch TR, Levitt R, Windschitl HE, Knost JA, Tschetter LK. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. Cancer 2005, 103:111-8. 10.1002/cncr.20753, 15558814.
8. Jeter MD, Janne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 2002, 53:394-400.
9. Ben-Josef E, Shamsa F, Williams AO, Porter AT. Radiotherapeutic management of osseous metastases: a survey of current patterns of care. Int J Radiat Oncol Biol Phys 1998, 40:915-21. 10.1016/S0360-3016(97)00927-9, 9531377.
10. Hayashi S, Hoshi H, Iida T, Kajiura Y. Multi-fractionated wide-field radiation therapy for palliation of multiple symptomatic bone metastases from solid tumors. Radiat Med 1999, 17:411-6.
11. Tsujino K, Hirota S, Endo M, Obayashi K, Kotani Y, Satouchi M, Kado T, Takada Y. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003, 55:110-5. 10.1016/S0360-3016(02)03807-5, 12504042.
12. Belderbos JS, Heemsbergen WD, De Jaeger K, Baas P, Lebesque JV. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006, 66:126-34.
13. Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 2004, 100:1793-9. 10.1002/cncr.20229, 15112258.
14. Choi YW, Munden RF, Erasmus JJ, Park KJ, Chung WK, Jeon SC, Park CK. Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics 2004, 24:985-97. discussion 98, 10.1148/rg.244035160, 15256622.
15. Khan MA, Hill RP, Van Dyk J. Partial volume rat lung irradiation: an evaluation of early DNA damage. Int J Radiat Oncol Biol Phys 1998, 40:467-76.
16. Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 1995, 31:361-9.
17. Eckert F, Muller AC. SCLC extensive disease--treatment guidance by extent or/and biology of response?. Radiat Oncol 2008, 3:33. 10.1186/1748-717X-3-33, 2570671, 18831728.
18. Sedelnikova OA, Nakamura A, Kovalchuk O, Koturbash I, Mitchell SA, Marino SA, Brenner DJ, Bonner WM. DNA double-strand breaks form in bystander cells after microbeam irradiation of three-dimensional human tissue models. Cancer Res 2007, 67:4295-302. 10.1158/0008-5472.CAN-06-4442, 17483342.
19. Prise KM, O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 2009, 9:351-60. 10.1038/nrc2603, 19377507.
20. Kim JY, Kim YS, Kim YK, Park HJ, Kim SJ, Kang JH, Wang YP, Jang HS, Lee SN, Yoon SC. The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients. Radiat Oncol 2009, 4:59. 10.1186/1748-717X-4-59, 2789091, 19943923.
21. Schuring D, Hurkmans CW. Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose. Radiat Oncol 2008, 3:21. 10.1186/1748-717X-3-21, 2515326, 18662379.
22. Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008, 3:36. 10.1186/1748-717X-3-36, 2596155, 18976463.
23. Yamashita H, Nakagawa K, Nakamura N, Koyanagi H, Tago M, Igaki H, Shiraishi K, Sasano N, Ohtomo K. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2007, 2:21. 10.1186/1748-717X-2-21, 1894806, 17553175.